Literature DB >> 26429665

ω-3 Fatty acids reverse lipotoxity through induction of autophagy in nonalcoholic fatty liver disease.

Yi Chen1, Chengfu Xu1, Tianlian Yan1, Chaohui Yu1, Youming Li2.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the effect of ω-3 fatty acids on nonalcoholic fatty liver disease concerning hepatocyte lipid accumulation as well as apoptosis induced by free fatty acids (FFAs) and to explore the underlying mechanism involving autophagy.
METHODS: Hepatocytes were incubated with a mixture of free fatty acids (FFAs) to mimic in vitro lipotoxicity in the pathogenesis of nonalcoholic fatty liver disease, presented by lipid accumulation and cellular apoptosis. Chemical inhibitor or inducer of autophagy and genetic deficit cells, as well as ω-3 fatty acids were used as intervention. The autophagic role of ω-3 fatty acids was investigated using Western blot and immunofluorescence. The underlying mechanism of ω-3 fatty acids involving autophagy was preliminarily explored by quantitative real-time polymerase chain reaction and Western blot.
RESULTS: FFAs induce lipid accumulation and apoptosis in hepatocytes. Inhibition or genetic defect of autophagy increases lipid accumulation induced by FFA, whereas induction acts inversely. ω-3 Fatty acids reduced lipid accumulation and inhibited apoptosis induced by FFA. ω-3 Fatty acids induced autophagy by downregulating stearoyl-CoA desaturase 1 expression in hepatocytes.
CONCLUSION: ω-3 Fatty acids exert protective effects on hepatocytes against lipotoxicity through induction of autophagy, as demonstrated by inhibition of lipid accumulation and apoptosis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; Lipotoxicity; Nonalcoholic fatty liver disease; Stearoyl-CoA desaturase 1; ω-3 Fatty acids

Mesh:

Substances:

Year:  2015        PMID: 26429665     DOI: 10.1016/j.nut.2015.05.022

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  12 in total

Review 1.  Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis.

Authors:  Yifeng Wang; Wen-Xing Ding; Tiangang Li
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-04-10       Impact factor: 4.698

Review 2.  Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management.

Authors:  Yingmei Zhang; Adam T Whaley-Connell; James R Sowers; Jun Ren
Journal:  Pharmacol Ther       Date:  2018-06-22       Impact factor: 12.310

Review 3.  Renal Cellular Autophagy in Obesity: Boon or Bane?

Authors:  Ramyar Ghandriz; Lilach O Lerman
Journal:  Semin Nephrol       Date:  2021-07       Impact factor: 4.472

4.  Maresin 1 mitigates liver steatosis in ob/ob and diet-induced obese mice.

Authors:  L M Laiglesia; S Lorente-Cebrián; L Martínez-Fernández; N Sáinz; P L Prieto-Hontoria; M A Burrell; C M Rodríguez-Ortigosa; J A Martínez; M J Moreno-Aliaga
Journal:  Int J Obes (Lond)       Date:  2017-09-12       Impact factor: 5.095

Review 5.  Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase.

Authors:  Niharika Samala; Sarah A Tersey; Naga Chalasani; Ryan M Anderson; Raghavendra G Mirmira
Journal:  J Diabetes Complications       Date:  2017-07-31       Impact factor: 2.852

6.  Non-alcoholic fatty liver disease--a chronic disease of the 21<sup>st</sup> century.

Authors:  Peter Metrakos; Tommy Nilsson
Journal:  J Biomed Res       Date:  2018-09-29

7.  Fish oil reverses metabolic syndrome, adipocyte dysfunction, and altered adipokines secretion triggered by high-fat diet-induced obesity.

Authors:  Roberta D C da Cunha de Sá; Maysa M Cruz; Talita M de Farias; Viviane S da Silva; Jussara de Jesus Simão; Monica M Telles; Maria Isabel C Alonso-Vale
Journal:  Physiol Rep       Date:  2020-02

8.  Dexmedetomidine ameliorates high-fat diet-induced nonalcoholic fatty liver disease by targeting SCD1 in obesity mice.

Authors:  Linfen Tao; Xiaolong Guo; Min Xu; Yumeng Wang; Wenhua Xie; Hong Chen; Mengyao Ma; Xi Li
Journal:  Pharmacol Res Perspect       Date:  2021-02

9.  Fish Oil Enriched in EPA, but Not in DHA, Reverses the Metabolic Syndrome and Adipocyte Dysfunction Induced by a High-Fat Diet.

Authors:  Roberta Dourado Cavalcante da Cunha de Sá; Jussara de Jesus Simão; Viviane Simões da Silva; Talita Mendes de Farias; Maysa Mariana Cruz; Vitor Jacó Antraco; Lucia Armelin-Correa; Maria Isabel Alonso-Vale
Journal:  Nutrients       Date:  2021-02-26       Impact factor: 5.717

10.  Effects of Long-Term DHA Supplementation and Physical Exercise on Non-Alcoholic Fatty Liver Development in Obese Aged Female Mice.

Authors:  Jinchunzi Yang; Neira Sáinz; Elisa Félix-Soriano; Eva Gil-Iturbe; Rosa Castilla-Madrigal; Marta Fernández-Galilea; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  Nutrients       Date:  2021-02-03       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.